Skip to content

GlobalLawDBby GenieAI

Laws Search Sanctions Map Data Developers

Search the text of the law

Log in Get an API key

Laws Search Sanctions Map Data Developers

Log in Get an API key

The Global Law Database. Free to read, built for people and AI agents.

Explore

All laws
Search the text
Sanctions
Map of connections
Compare UK and EU

Developers

AI agents (MCP)
REST API
Bulk data
API keys

Coverage

United Kingdom
European Union
United States
Canada
Australia
France
Germany
Netherlands
Spain
Austria
Norway
Finland
Switzerland
Ireland

GlobalLawDB is made by GenieAI, London. It is not legal advice: check the official text before relying on it. Text comes from official publishers under their licences, listed on the Data page.

ThemeMatch my systemLightDark

European Union
Novo Nordisk AS v Ravimiamet (C-249/09)
Judgment
Consideration of the questions referred
The first question
25

Novo Nordisk AS v Ravimiamet (C-249/09)

law://eu/cjeu/2009/c-249-09/para_25@2026-11-12

Key facts

Court: Court of Justice · Third Chamber
Case: C-249/09 · ECLI:EU:C:2011:272
Decided: 5 May 2011
Procedure: Preliminary reference · referred by the Tartu ringkonnakohus (Estonia)
Applicant: Novo Nordisk AS
Defendant: Ravimiamet
Rapporteur: D. Šváby
Advocate General: N. Jääskinen
Bench: 5 judges
K. Lenaerts, D. Šváby, R. Silva de Lapuerta, E. Juhász, J. Malenovský
Language: Estonian
Official: CURIA · EUR-Lex 62009CJ0249

Topics

Approximation of laws

History · 1 version

5 May 2011Reading

Judgment of 5 May 2011

25Similarly, it is clear from the wording and the content of Article 87 of Directive 2001/83 that that provision contains general principles applicable to all types and parts of advertising for medicinal products.

Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.

Connections

Interprets 1: Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
Cited by 4: SIA 'EUROAPTIEKA' v Ministru kabinets (C-530/20)2 provisions; ratiopharm GmbH v Novartis Consumer Health GmbH (C-786/18); Fresenius Kabi Austria GmbH and Others v European Commission (T-416/22); Laboratoires CTRS v European Commission (T-452/14)
Cites 3: Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use; The Queen, on the application of Association of the British Pharmaceutical Industry v Medicines and Healthcare Products Regulatory Agency (C-62/09); Criminal proceedings against Frede Damgaard (C-421/07)